Meet Brittany, Our New Marketing Manager!

Brittany Carney may be the newest member of the TCOYD team, but she already feels like family. With her youthful energy, creative vision and marketing prowess, she’s ready to lead us in our communication efforts. Until you get the chance to meet her in person at a conference, get to know her a little bit here!

read more

Evaluating Type 2 Meds, Part 5: SGLT-2 (Sodium-Glucose Co-Transporter 2) Inhibitors

SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.

read more